Eating Disorder & Weight Loss Ads: A Dangerous Mix?

The rapid rise of telehealth-driven weight-loss treatments, particularly those utilizing GLP-1 medications like Ozempic and Wegovy, is facing increasing scrutiny. While offering potential benefits for individuals struggling with obesity, the aggressive marketing tactics employed by some companies – including Black Friday sales and circumvention of advertising regulations – are raising serious concerns about patient safety … Read more